Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kairos Pharma (KAPA) Free Cash Flow (2024 - 2025)

Historic Free Cash Flow for Kairos Pharma (KAPA) over the last 2 years, with Q2 2025 value amounting to -$805000.0.

  • Kairos Pharma's Free Cash Flow fell 37916.67% to -$805000.0 in Q2 2025 from the same period last year, while for Jun 2025 it was -$5.3 million, marking a year-over-year change of. This contributed to the annual value of -$4.0 million for FY2024, which is 498271.6% down from last year.
  • Latest data reveals that Kairos Pharma reported Free Cash Flow of -$805000.0 as of Q2 2025, which was down 37916.67% from -$714000.0 recorded in Q1 2025.
  • Kairos Pharma's Free Cash Flow's 5-year high stood at $36000.0 during Q1 2024, with a 5-year trough of -$2.0 million in Q3 2024.